Pharmaceutical News and Articles

CDC Estimates 1.4 Million ED Visits/Year for Those Experiencing Homelessness

During 2016 to 2021, an estimated 1.4 million emergency department visits were made per year among people experiencing homelessness, according to a study publis

FDA Approves Farxiga (dapagliflozin) for Glycemic Control in Children Aged 10 Years and Older with Type-2 Diabetes

Exercise at One Time of Day Might Be Best for Blood Sugar Control

Folks trying to control their blood sugar levels might do best to work out in the evening, a new study suggests. Exercise performed between 6 p.m. and midnight

Generation X Experiencing Larger Per-Capita Increases in Cancer Incidence

Generation X is experiencing larger per-capita increases in the incidence of cancers than Baby Boomers, according to a study published online June 10 in JAMA Ne

Patients Can Take GLP-1 RA Medications Before Surgery

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications do slow gastric emptying but not by enough to warrant discontinuing medications before surgery,

Females Have Higher Genetic Risk for PTSD

The genetic influences of posttraumatic stress disorder (PTSD) are stronger in females than males, according to a study published online June 4 in The American

Dad Plays Role in His Infant's Microbiome

that typically play key roles in daily human health. They are known to stimulate the immune system, break down toxins, aid in digestion and synthesize certain k

AI-Based Health Coaching Aids Blood Pressure Management

Artificial intelligence (AI)-based, lifestyle coaching can improve blood pressure (BP) management, according to a study published online May 28 in JMIR Cardio.J

9/11 Responders May Face Higher Odds for Dementia

namely, that consistent PPE use can spare workers in similar situations from future illness and early death. There is a critical need to protect persons who hel

Tau PET Performs Well in Predicting Dementia in Individuals With MCI

Tau positron emission tomography (PET) has the best performance as a standalone marker for prediction of progression of mild cognitive impairment (MCI) to demen